This company listing is no longer active
Signify Health Management
Management criteria checks 4/4
Key information
Bradford Armbrester
Chief executive officer
US$2.5m
Total compensation
| CEO salary percentage | 24.4% |
| CEO tenure | 4.9yrs |
| CEO ownership | 1.3% |
| Management average tenure | 2.9yrs |
| Board average tenure | 4.9yrs |
Recent management updates
Recent updates
CVS Health to offer bonds to finance purchase of Signify Health
Feb 13Signify Health and Prospect Medical come together to deliver coordinated, high-quality care
Jan 11Checking Signify Health Before The CVS Transaction
Dec 21Signify expands diagnostic offering with spirometry test for lung disease
Oct 18Signify Health jumps on report CVS in talks to acquire for about $8 billion
Sep 02Signify Health: Cathie Wood Now Selling
Aug 15CVS Health seeking purchase of Signify Health - WSJ
Aug 07Signify Health: ECS Wind Down Sheds Light On Compelling Valuation
Jul 21Signify Health Aims Higher With New CMS Terms
Mar 16Revisiting Signify Health
Jan 09Signify Health names Susan Yun as chief people officer
Jun 02CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2022 | n/a | n/a | US$77m |
| Sep 30 2022 | n/a | n/a | -US$518m |
| Jun 30 2022 | n/a | n/a | -US$338m |
| Mar 31 2022 | n/a | n/a | US$32m |
| Dec 31 2021 | US$2m | US$600k | US$43m |
| Sep 30 2021 | n/a | n/a | -US$3m |
| Jun 30 2021 | n/a | n/a | -US$23m |
| Mar 31 2021 | n/a | n/a | -US$23m |
| Dec 31 2020 | US$15m | US$605k | -US$25m |
| Sep 30 2020 | n/a | n/a | -US$8m |
| Dec 31 2019 | US$5m | US$600k | US$0 |
Compensation vs Market: Bradford's total compensation ($USD2.46M) is below average for companies of similar size in the US market ($USD8.34M).
Compensation vs Earnings: Bradford's compensation has been consistent with company performance over the past year.
CEO
Bradford Armbrester (37 yo)
4.9yrs
Tenure
US$2,457,417
Compensation
Mr. Bradford Kyle Armbrester is Director at R1 RCM Inc. from June 2022. He serves as Chief Executive Officer and a Director at Signify Health Inc. since April 2018. Mr. Armbrester has been the Chief Execut...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 4.9yrs | US$2.46m | 1.31% $ 94.2m | |
| Chief Technology Officer | 2.8yrs | US$3.09m | 0.0037% $ 264.7k | |
| President | 3.3yrs | US$3.32m | 0.091% $ 6.6m | |
| Chief Operating Officer | 5.3yrs | no data | 0.018% $ 1.3m | |
| Chief Accounting Officer | no data | no data | 0.0043% $ 311.5k | |
| Vice President of Investor Relations | 1.2yrs | no data | no data | |
| General Counsel & Secretary | 3.3yrs | no data | 0.025% $ 1.8m | |
| Chief Compliance Officer | 1.7yrs | no data | no data | |
| Vice President of Strategic Communications | no data | no data | no data | |
| Chief People Officer | 1.8yrs | no data | no data | |
| Executive Vice President of Value-Based Care Sales | 3.1yrs | no data | 0.0056% $ 403.1k | |
| Chief Medical Officer | 2.8yrs | no data | 0.0040% $ 284.8k |
2.9yrs
Average Tenure
47yo
Average Age
Experienced Management: SGFY's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 4.9yrs | US$2.46m | 1.31% $ 94.2m | |
| Independent Director | 4.9yrs | US$259.98k | 0.070% $ 5.0m | |
| Director | 9.9yrs | US$262.48k | 0.34% $ 24.8m | |
| Independent Director | 5.3yrs | US$259.98k | no data | |
| Independent Chairman | 5.3yrs | US$284.98k | no data | |
| Independent Director | 5.3yrs | US$289.98k | no data | |
| Independent Director | 1.6yrs | US$405.22k | 0.010% $ 727.6k | |
| Independent Director | 2.7yrs | US$269.36k | 0.0064% $ 462.2k | |
| Independent Director | 1.9yrs | US$425.81k | 0.0084% $ 604.3k | |
| Independent Director | 3.1yrs | US$265.61k | 0.012% $ 878.3k |
4.9yrs
Average Tenure
52yo
Average Age
Experienced Board: SGFY's board of directors are considered experienced (4.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/03/30 08:29 |
| End of Day Share Price | 2023/03/28 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Signify Health, Inc. is covered by 14 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| Steven Valiquette | Barclays |
| Sarah James | Barclays |